Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for Primary Sjogren's Syndrome Glandular Damage

NCT06519617 is registered in ClinicalTrials.gov with Qingwen Tao as lead sponsor.

NCT NCT06519617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06519617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for Primary Sjogren's Syndrome Glandular Damage
Lead sponsor
Qingwen Tao
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
July 13, 2024
Completion date
December 31, 2026
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary sjögren syndrome